Study on the Changes in Medical Expenses for Chronic Diseases in Shanxi Province from 2019 to 2022 Based on"SHA 2011"
- VernacularTitle:基于"SHA 2011"的2019-2022年山西省慢性病治疗费用变化研究
- Author:
Hong WANG
1
;
Yunxia ZHANG
;
Ying HAN
Author Information
1. 山西医科大学 山西 太原 030001
- Publication Type:Journal Article
- Keywords:
A System of Health Accounts 2011;
chronic disease;
treatment cost;
Shanxi
- From:
Chinese Health Economics
2025;44(4):56-60
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze the changes of chronic disease treatment cost in Shanxi,to clarify priorities in chronic disease prevention and control,and provide recommendations for optimizing chronic disease prevention policies.Methods:"SHA 2011"accounting framework was used to measure the change of chronic disease treatment costs.Results:The proportion of chronic diseases in treatment cost remained at about 70%.The proportion of chronic disease treatment cost in general hospital is the highest.The proportion of chronic disease treatment expenses of 45-59 years old is second only to that of 60-74 years old.The proportion of treatment expenses for circulatory diseases should be kept above 25%;the main sources of financing is social medical insurance.Conclusion:The avoidable hospitalization cost of chronic diseases is high.The cost of chronic disease treatment is becoming younger.The health financing structure of chronic diseases tends to be reasonable.In order to further improve the prevention and control effect of chronic diseases and the efficiency of the use of chronic disease resources in Shanxi,it is necessary to improve the effectiveness of key policies,reduce the incidence of chronic diseases;improve the medical insurance reimbursement policy,optimize the use of inpatient services;strengthen the urban medical alliances,guide key groups to seek medical treatment reasonably;optimize the financial compensation and medical insurance payment policy,and improve the multi-channel financing mechanism
